interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Tenofovir Disoproxil Fumarate

Generic competition · all medicines · read 12 November 2026

Is there a generic of Tenofovir Disoproxil Fumarate, and who makes it?

Tenofovir Disoproxil Fumarate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 11 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 13.4 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Tenofovir Disoproxil Fumarate2 dosage-form groups in the Orange Book
11generic makers listed
  1. Tenofovir Disoproxil Fumarate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 11 generic makers listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came 13.4 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Four or more generic makers listed

Brand listed as marketed: Viread. 11 generic makers with 19 generic products listed as marketed; the first generic approval is dated 18 March 2015.

2000200520102015202020252030011brand 2001Teva Pharmaceuticals Usa, first approval 18 March 2015Aurobindo Pharma Ltd, first approval 26 January 2018Cipla Ltd, first approval 26 January 2018Hetero Labs Ltd Unit Iii, first approval 26 January 2018Macleods Pharmaceuticals Ltd, first approval 26 January 2018Strides Pharma Global Pte Ltd, first approval 26 January 2018Qilu Pharmaceutical Co Ltd, first approval 2 March 2018Chartwell Life Molecules Llc, first approval 26 July 2018Reyoung Corporation, first approval 2 March 2023Pharmobedient Consulting Llc, first approval 29 February 2024Micro Labs Ltd, first approval 18 December 2025data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Teva Pharmaceuticals Usa18 March 20154
Aurobindo Pharma Ltd26 January 20184
Cipla Ltd26 January 20181
Hetero Labs Ltd Unit Iii26 January 20181
Macleods Pharmaceuticals Ltd26 January 20181
Strides Pharma Global Pte Ltd26 January 20181
Qilu Pharmaceutical Co Ltd2 March 20183
Chartwell Life Molecules Llc26 July 20181
Reyoung Corporation2 March 20231
Pharmobedient Consulting Llc29 February 20241
Micro Labs Ltd18 December 20251

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Powder, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Viread. No generic is listed as marketed.

2010201520202025203001brand 2012data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.